Avinger, Inc. (AVGR): Price and Financial Metrics

Avinger, Inc. (AVGR): $2.90

0.01 (-0.34%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

AVGR Price/Volume Stats

Current price $2.90 52-week high $18.00
Prev. close $2.91 52-week low $2.50
Day low $2.87 Volume 10,900
Day high $3.07 Avg. volume 59,492
50-day MA $3.11 Dividend yield N/A
200-day MA $5.87 Market Cap 3.97M

AVGR Stock Price Chart Interactive Chart >

AVGR POWR Grades

  • Sentiment is the dimension where AVGR ranks best; there it ranks ahead of 95.61% of US stocks.
  • The strongest trend for AVGR is in Sentiment, which has been heading up over the past 83 days.
  • AVGR's current lowest rank is in the Momentum metric (where it is better than 3.86% of US stocks).

AVGR Stock Summary

  • AVGR has a market capitalization of $3,822,629 -- more than approximately just 1.99% of US stocks.
  • AVGR's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 1.66% of US stocks.
  • In terms of volatility of its share price, AVGR is more volatile than 98.29% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to AVINGER INC are OGN, ADTX, LEU, RIGL, and MTCH.
  • Visit AVGR's SEC page to see the company's official filings. To visit the company's web site, go to www.avinger.com.

AVGR Valuation Summary

  • In comparison to the median Healthcare stock, AVGR's price/sales ratio is 88.1% lower, now standing at 0.5.
  • AVGR's price/sales ratio has moved down 11.3 over the prior 108 months.

Below are key valuation metrics over time for AVGR.

Stock Date P/S P/B P/E EV/EBIT
AVGR 2023-12-29 0.5 -2.7 -0.2 -0.6
AVGR 2023-12-28 0.5 -3.0 -0.2 -0.6
AVGR 2023-12-27 0.5 -2.9 -0.2 -0.6
AVGR 2023-12-26 0.5 -2.9 -0.2 -0.6
AVGR 2023-12-22 0.5 -2.8 -0.2 -0.6
AVGR 2023-12-21 0.5 -2.7 -0.2 -0.6

AVGR Growth Metrics

    The year over year cash and equivalents growth rate now stands at -34.29%.
  • Its 3 year price growth rate is now at -98.32%.
  • The 3 year cash and equivalents growth rate now stands at 19.75%.
AVGR's revenue has moved down $1,720,000 over the prior 15 months.

The table below shows AVGR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 8.675 -17.574 -27.972
2022-06-30 8.789 -17.7 -28.714
2022-03-31 9.459 -17.075 -26.869
2021-12-31 10.13 -15.697 -21.587
2021-09-30 10.459 -15.33 -21.143
2021-06-30 10.395 -14.984 -20.679

AVGR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AVGR has a Quality Grade of D, ranking ahead of 16.95% of graded US stocks.
  • AVGR's asset turnover comes in at 0.276 -- ranking 136th of 186 Medical Equipment stocks.
  • HOLX, ICAD, and BTCY are the stocks whose asset turnover ratios are most correlated with AVGR.

The table below shows AVGR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.276 0.353 -1.054
2021-03-31 0.257 0.332 -1.360
2020-12-31 0.288 0.299 -1.795
2020-09-30 0.306 0.298 -2.297
2020-06-30 0.336 0.303 -2.235
2020-03-31 0.369 0.314 -1.990

AVGR Price Target

For more insight on analysts targets of AVGR, see our AVGR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.50 Average Broker Recommendation 1.5 (Moderate Buy)

Avinger, Inc. (AVGR) Company Bio


Avinger, Inc. designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease in the United States and Europe. The company was founded in 2007 and is based in Redwood City, California.


AVGR Latest News Stream


Event/Time News Detail
Loading, please wait...

AVGR Latest Social Stream


Loading social stream, please wait...

View Full AVGR Social Stream

Latest AVGR News From Around the Web

Below are the latest news stories about AVINGER INC that investors may wish to consider to help them evaluate AVGR as an investment opportunity.

Avinger, Inc. (NASDAQ:AVGR) Q3 2023 Earnings Call Transcript

Avinger, Inc. (NASDAQ:AVGR) Q3 2023 Earnings Call Transcript October 26, 2023 Avinger, Inc. misses on earnings expectations. Reported EPS is $-2.92 EPS, expectations were $-2.85. Operator: Greetings. Welcome to the Avinger Third Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. […]

Yahoo | October 27, 2023

Avinger (AVGR) Reports Q3 Loss, Lags Revenue Estimates

Avinger (AVGR) delivered earnings and revenue surprises of -2.46% and 24.29%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | October 26, 2023

Avinger Reports Third Quarter 2023 Results

REDWOOD CITY, CA / ACCESSWIRE / October 26, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of ...

Yahoo | October 26, 2023

Avinger to Announce Third Quarter 2023 Results on October 26

REDWOOD CITY, CA / ACCESSWIRE / October 19, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, ...

Yahoo | October 19, 2023

Avinger Raises $5.3 Million via At-The-Market Facility

Strengthens Balance Sheet in Support of Tigereye ST Launch and Coronary Product DevelopmentREDWOOD CITY, CA / ACCESSWIRE / September 27, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular ...

Yahoo | September 27, 2023

Read More 'AVGR' Stories Here

AVGR Price Returns

1-mo -2.52%
3-mo 6.99%
6-mo -74.06%
1-year -76.62%
3-year -99.44%
5-year -99.90%
YTD 7.01%
2023 -83.35%
2022 -87.94%
2021 2.25%
2020 -61.39%
2019 -62.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!